Research and Studies on Prevagen®
Read about the efficacy and safety of Prevagen’s main ingredient
Madison Memory Study
In a double-blinded, placebo-controlled trial, Prevagen demonstrated the ability to improve aspects of cognitive function over 90 days in participants with either normal cognitive aging or very mild impairment, as determined by pre-trial screening.
Safety Study I
Apoaequorin, the main ingredient in Prevagen, showed no adverse effects when taken orally using a toxicity study for evaluating dietary supplements.
Safety Study II
Apoaequorin has not shown to have any significant risk of allergic reactivity when ingested.
Safety Study III
In a third study conducted on the safety of apoaequorin, apoaequorin showed no adverse effects when taken orally.